What is the current Price Target for the Edgewise Therapeutics Inc stock?

The average Edgewise Therapeutics Inc target price is $42.33. This is 180.33% higher than the current stock price. The highest price target is 254.64%, the lowest is -6.36%. 15 Analysts have issued a price target Edgewise Therapeutics Inc 2026 .

How high will the Edgewise Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Edgewise Therapeutics Inc stock will rise. The performance of stocks, including the Edgewise Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Edgewise Therapeutics Inc stock today?

The performance of Edgewise Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Edgewise Therapeutics Inc stock fall?

The decline in Edgewise Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Edgewise Therapeutics Inc Forecast, price target & analysts

$15.10

1.41% yesterday

Nasdaq, Oct 23, 10:15 pm CET

ISIN

US28036F1057

Symbol

EWTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Edgewise Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Edgewise Therapeutics Inc Classifications & Recommendation:

Buy

79%

Hold

21%

Edgewise Therapeutics Inc Price Target

Target Price	$42.33
Price	$15.10
Potential	180.33% register free of charge
Number of Estimates	15

	15 Analysts have issued a price target Edgewise Therapeutics Inc 2026 . The average Edgewise Therapeutics Inc target price is $42.33. This is 180.33% register free of charge higher than the current stock price. The highest price target is $53.55 254.64% register free of charge , the lowest is $14.14 6.36% register free of charge .
	A rating was issued by 19 analysts: 15 Analysts recommend Edgewise Therapeutics Inc to buy, 4 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Edgewise Therapeutics Inc stock has an average upside potential 2026 of 180.33% register free of charge . Most analysts recommend the Edgewise Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.45	-1.65
	7.64%	13.79%
P/E		negative

15 Analysts have issued a Edgewise Therapeutics Inc forecast for earnings per share. The average Edgewise Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.45	7.64%
2025	$-1.65 13.79% Unlock
2026	$-2.01 21.82% Unlock
2027	$-2.09 3.98% Unlock
2028	$-1.41 32.54% Unlock
2029	$0.51 136.17% Unlock
2030	$2.43 376.47% Unlock
2031	$4.26 75.31% Unlock
2032	$7.32 71.83% Unlock

Current	-10.56	60.81%
2025	-9.17 13.16% Unlock
2026	-7.51 18.10% Unlock
2027	-7.21 3.99% Unlock
2028	-10.73 48.82% Unlock
2029	29.86 378.29% Unlock
2030	6.22 79.17% Unlock
2031	3.55 42.93% Unlock
2032	2.06 41.97% Unlock

Edgewise Therapeutics Inc...

Current Edgewise Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Goldman Sachs	Locked ➜ Locked	Locked	Sep 25 2025
JP Morgan	Locked ➜ Locked	Locked	Aug 19 2025
RBC Capital	Locked ➜ Locked	Locked	Aug 08 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 30 2025
RBC Capital	Locked ➜ Locked	Locked	Jun 05 2025
Wedbush	Locked ➜ Locked	Locked	Apr 21 2025
Scotiabank	Locked ➜ Locked	Locked	Apr 03 2025

Analyst Rating	Date
Locked Goldman Sachs: Locked ➜ Locked	Sep 25 2025
Locked JP Morgan: Locked ➜ Locked	Aug 19 2025
Locked RBC Capital: Locked ➜ Locked	Aug 08 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 30 2025
Locked RBC Capital: Locked ➜ Locked	Jun 05 2025
Locked Wedbush: Locked ➜ Locked	Apr 21 2025
Locked Scotiabank: Locked ➜ Locked	Apr 03 2025

Discover more stocks with a high price target

TUI 51.95%

BioNTech SE - ADR 33.40%

Deutsche Telekom 32.24%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now